Consumption, phthisis, the white plague—a killer by any other name, tuberculosis (TB) has stalked humanity since at least the ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials, as part of a successful collaboration between three leading ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials. A new vaccine that boosts immunity against tuberculosis (TB ...

The vaccine candidate, being developed by Professor Deepak Kaushal, Ph.D., involves a weakened or “attenuated” strain of Mycobacterium tuberculosis (Mtb), the bacterium that causes TB.

IC31 did not reduce the risk of recurrent disease in individuals who completed treatment for pulmonary tuberculosis.

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently approved vaccine for TB – which recently surpassed COVID-19 to once again ...

The current status of TB vaccine development and testing is very encouraging. Several new TB vaccines are currently in Phase I or IIa human trials and field sites for eventual Phase III efficacy ...

Xin Wang et al, Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal models, Nature Microbiology (2025). DOI: 10.1038/s41564-024-01913-5 ...

Henry "Rique" Campa III, a professor of wildlife ecology in Michigan State University's Department of Fisheries and Wildlife, came up with the idea of testing TB vaccination of wild deer in the ...